Ark Therapeutics wins acceptance of diagnostic test

Ark Therapeutics Group Plc has been told by the UK National Health Service that its diagnostic test for detecting early stage peripheral autonomic neuropathy in the feet of diabetic patients has been accepted for reimbursement.